Publications by authors named "Per Lundborg"

Claim this Profile
P
Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Taher Omari, Geoffrey Davidson, Patrik Bondarov, Emma Nauclér, Catarina Nilsson, Per Lundborg

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Taher Omari, Geoffrey Davidson, Patrik Bondarov, Emma Nauclér, Catarina Nilsson, Per Lundborg

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitization to omeprazole in the occupational setting.
Per Hamid Ghatan, Maritha Marcusson-Ståhl, Mihaly Matura, Carol Björkheden, Per Lundborg

Contact Dermatitis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetic properties of esomeprazole in children aged 1 - 11 years with endoscopically proven GERD: a randomized, open-label study.
Nader N Youssef, Eduardo Tron, Vasundhara Tolia, Jennifer E Hamer-Maansson, Per Lundborg

Int J Clin Pharmacol Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
Geoffrey Davidson, Tobias G Wenzl, Michael Thomson, Taher Omari, Peter Barker, Per Lundborg

J Pediatr· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
Marie Sandström, Geoffrey Davidson, Vasundhara Tolia, Janice E Sullivan, Göran Långström, Per Lundborg

Clin Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of peptic ulcer bleeding in the US pediatric population.
Kurt Brown, Per Lundborg, Jeremy Levinson, Huiying Yang

J Pediatr Gastroenterol Nutr· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
Ana Ruigómez, A Pali Hungin, Per Lundborg, Saga Johansson, Mari-Ann Wallander

Eur J Gastroenterol Hepatol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.
Marta Illueca, Börje Wernersson, Catherine Henderson, Per Lundborg

J Pediatr Gastroenterol Nutr· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis.
Ana Ruigómez, Per Lundborg, Saga Johansson, Mari-Ann Wallander, Luis A García Rodríguez

Scand J Gastroenterol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastroesophageal reflux disease in children and adolescents in primary care.
Ana Ruigómez, Mari-Ann Wallander, Per Lundborg, Saga Johansson, Luis A Garcia Rodriguez

Scand J Gastroenterol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.
Taher Omari, Per Lundborg, Marie Sandström, Patrik Bondarov, Mia Fjellman

J Pediatr· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.
John Dent, Peter J Kahrilas, Jan Hatlebakk, Nimish Vakil, Hans Denison, Per Lundborg

Am J Gastroenterol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
Taher Omari, Geoffrey Davidson, Patrik Bondarov, Emma Nauclér, Catarina Nilsson, Per Lundborg

J Pediatr Gastroenterol Nutr· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Taher I Omari, Ross R Haslam, Per Lundborg, Geoffrey P Davidson

J Pediatr Gastroenterol Nutr· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study.
June Zhao, Jianguo Li, Jennifer E Hamer-Maansson, Tommy Andersson, Rose Fulmer, Per Lundborg

Clin Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study.
Jianguo Li, June Zhao, Jennifer E Hamer-Maansson, Tommy Andersson, Rose Fulmer, Per Lundborg

Clin Ther· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis